UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantitation of Activated Factor VII Levels in Plasma Using a Tissue Factor Mutant Selectively Deficient in Promoting Factor VII Activation

Blood, 1993-02, Vol.81 (3), p.734-744

1993

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

Clinical pharmacology and therapeutics, 1994-06, Vol.55 (6), p.638-648

1994

Volltextzugriff (PDF)

Treatment of Factor VIII Inhibitors: Products and Strategies

Seminars in thrombosis and hemostasis, 1993-01, Vol.19 (1), p.13-24

Macik, B. Gail

1993

Volltextzugriff (PDF)

Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis

American journal of hematology, 1994-02, Vol.45 (2), p.128-135

1994

Volltextzugriff (PDF)

Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings

Radiology, 1994-08, Vol.192 (2), p.531-537

1994

Volltextzugriff (PDF)

Designing a point-of-care program for coagulation testing

Archives of pathology & laboratory medicine (1976), 1995-10, Vol.119 (10), p.929

Macik, B G

1995

Volltextzugriff (PDF)

Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor

Thrombosis research, 1989-12, Vol.56 (5), p.603-609

1989

Volltextzugriff (PDF)

Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report

Prenatal diagnosis, 1994-09, Vol.14 (9), p.873-877

1994

Volltextzugriff (PDF)

Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy

Liver transplantation, 2003-02, Vol.9 (2), p.138-143

2003

Volltextzugriff (PDF)

Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study

Blood coagulation & fibrinolysis, 1993-08, Vol.4 (4), p.521-528

1993

Volltextzugriff (PDF)

Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach

Cancer research (Chicago, Ill.), 1983-04, Vol.43 (4), p.1703-1709

1983

Volltextzugriff (PDF)

CLINICAL AND LABORATORY EVALUATION OF THE HYPERCOAGULABLE STATES

Clinics in chest medicine, 1995-06, Vol.16 (2), p.375-387

1995

Volltextzugriff (PDF)

The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults

Nephrology, dialysis, transplantation, 1995, Vol.10 (7), p.1189-1193

1995

Volltextzugriff (PDF)

Thrombophilia: what's a practitioner to do?

Hematology, 2001, Vol.2001 (1), p.322-338

2001

Volltextzugriff (PDF)

Acquired autoantibodies to coagulation factors

Current opinion in hematology, 1999-09, Vol.6 (5), p.323-328

1999

Volltextzugriff (PDF)

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants

Urology (Ridgewood, N.J.), 2005-10, Vol.66 (4), p.830-834

2005

Volltextzugriff (PDF)

Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2

Clinical chemistry (Baltimore, Md.), 1994-10, Vol.40 (10), p.1962-1969

1994

Volltextzugriff (PDF)

Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

American journal of hematology, 1989-11, Vol.32 (3), p.232-234

1989

Volltextzugriff (PDF)

Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials

Hepatology (Baltimore, Md.), 2004-03, Vol.39 (3), p.592-598

2004

Volltextzugriff (PDF)

Evaluation of sensitivity and specificity of six D-dimer latex assays

Archives of pathology & laboratory medicine (1976), 1994-11, Vol.118 (11), p.1102

1994

Volltextzugriff (PDF)

In vitro evaluation of 2,4-dihydroxythiobenzanilides against various moulds

European journal of pharmaceutical sciences, 2001-06, Vol.13 (3), p.243-248

2001

Volltextzugriff (PDF)

The future of anticoagulation clinics

Journal of thrombosis and thrombolysis, 2003-08, Vol.16 (1-2), p.55-59

Macik, B Gail

2003

Volltextzugriff (PDF)

The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome

Archives of pathology & laboratory medicine (1976), 1988-02, Vol.112 (2), p.143

1988

Volltextzugriff (PDF)

Protein C inhibitor: Purification and proteinase reactivity

Thrombosis research, 1989-03, Vol.53 (6), p.595-602

1989

Volltextzugriff (PDF)

The heparin flush syndrome: a cause of iatrogenic hemorrhage

The American journal of the medical sciences, 1988-07, Vol.296 (1), p.71

1988

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Biological And Medical Sciences
(20)
Medical Sciences
(18)
Male
(12)
Adult
(10)
Female
(10)
Hematology
(10)
Middle Aged
(7)
Blood Coagulation Tests
(6)
Pharmacology. Drug Treatments
(6)
Adolescent
(5)
Hematologic And Hematopoietic Diseases
(5)
Cardiovascular System & Cardiology
(4)
Peripheral Vascular Disease
(4)
Platelet Diseases And Coagulopathies
(4)
Pregnancy
(4)
Anilides - Pharmacology
(3)
Antifungal Agents - Pharmacology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitation of Activated Factor VII Levels in Plasma Using a Tissue Factor Mutant Selectively Deficient in Promoting Factor VII Activation

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

Treatment of Factor VIII Inhibitors: Products and Strategies

Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis

Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings

Designing a point-of-care program for coagulation testing

Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor

Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report

Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy

Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study

Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach

CLINICAL AND LABORATORY EVALUATION OF THE HYPERCOAGULABLE STATES

The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults

Thrombophilia: what's a practitioner to do?

Acquired autoantibodies to coagulation factors

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants

Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2

Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials

Evaluation of sensitivity and specificity of six D-dimer latex assays

In vitro evaluation of 2,4-dihydroxythiobenzanilides against various moulds

The future of anticoagulation clinics

The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome

Protein C inhibitor: Purification and proteinase reactivity

The heparin flush syndrome: a cause of iatrogenic hemorrhage

Suchergebnisse filtern